A new trading day began on Tuesday, with Checkpoint Therapeutics Inc (NASDAQ: CKPT) stock price remained unchanged from the previous day of trading, before settling in for the closing price of $4.04. CKPT’s price has ranged from $1.38 to $4.50 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -49.45% over the past five years. Meanwhile, its annual earnings per share averaged 82.04%. With a float of $35.93 million, this company’s outstanding shares have now reached $53.64 million.
Let’s look at the performance matrix of the company that is accounted for 24 employees. In terms of profitability, gross margin is -45168.08%, operating margin of -79817.02%, and the pretax margin is -98868.09%.
Checkpoint Therapeutics Inc (CKPT) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Checkpoint Therapeutics Inc is 26.43%, while institutional ownership is 41.40%. The most recent insider transaction that took place on Feb 10 ’25, was worth 32,543. In this transaction CEO, President and Director of this company sold 10,331 shares at a rate of $3.15, taking the stock ownership to the 3,775,019 shares. Before that another transaction happened on Feb 07 ’25, when Company’s CEO, President and Director sold 9,233 for $3.41, making the entire transaction worth $31,485. This insider now owns 3,785,350 shares in total.
Checkpoint Therapeutics Inc (CKPT) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 82.04% per share during the next fiscal year.
Checkpoint Therapeutics Inc (NASDAQ: CKPT) Trading Performance Indicators
Here are Checkpoint Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.37. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8460.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.27, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach 1.13 in one year’s time.
Technical Analysis of Checkpoint Therapeutics Inc (CKPT)
Checkpoint Therapeutics Inc (NASDAQ: CKPT) saw its 5-day average volume 0.92 million, a negative change from its year-to-date volume of 2.4 million. As of the previous 9 days, the stock’s Stochastic %D was 58.12%. Additionally, its Average True Range was 0.12.
During the past 100 days, Checkpoint Therapeutics Inc’s (CKPT) raw stochastic average was set at 78.45%, which indicates a significant increase from 70.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 8.35% in the past 14 days, which was lower than the 105.09% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.35, while its 200-day Moving Average is $2.95. Nevertheless, the first resistance level for the watch stands at $4.06 in the near term. At $4.08, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.10. If the price goes on to break the first support level at $4.02, it is likely to go to the next support level at $4.00. Assuming the price breaks the second support level, the third support level stands at $3.98.
Checkpoint Therapeutics Inc (NASDAQ: CKPT) Key Stats
With a market capitalization of 338.41 million, the company has a total of 48,833K Shares Outstanding. Currently, annual sales are 40 K while annual income is -56,240 K. The company’s previous quarter sales were 0 K while its latest quarter income was -9,730 K.
